ATE334686T1 - Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie - Google Patents

Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie

Info

Publication number
ATE334686T1
ATE334686T1 AT00916269T AT00916269T ATE334686T1 AT E334686 T1 ATE334686 T1 AT E334686T1 AT 00916269 T AT00916269 T AT 00916269T AT 00916269 T AT00916269 T AT 00916269T AT E334686 T1 ATE334686 T1 AT E334686T1
Authority
AT
Austria
Prior art keywords
tumor therapy
improvement
sphingomyelin
composition containing
containing sphingomyelin
Prior art date
Application number
AT00916269T
Other languages
English (en)
Inventor
David Modrak
Original Assignee
Ct Molecular Med & Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Molecular Med & Immunology filed Critical Ct Molecular Med & Immunology
Application granted granted Critical
Publication of ATE334686T1 publication Critical patent/ATE334686T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00916269T 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie ATE334686T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12618999P 1999-03-25 1999-03-25

Publications (1)

Publication Number Publication Date
ATE334686T1 true ATE334686T1 (de) 2006-08-15

Family

ID=22423475

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00916269T ATE334686T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
AT06075201T ATE512664T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur behandlung der rheumatoiden arthritis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06075201T ATE512664T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur behandlung der rheumatoiden arthritis

Country Status (9)

Country Link
US (2) US6541462B1 (de)
EP (2) EP1165137B1 (de)
JP (1) JP2002540172A (de)
AT (2) ATE334686T1 (de)
AU (1) AU3740000A (de)
CA (2) CA2707691C (de)
DE (1) DE60029762T2 (de)
ES (1) ES2269121T3 (de)
WO (1) WO2000057916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683044B2 (en) * 1999-03-25 2010-03-23 Center For Molecular Medicine And Immunology Sphingomyelin therapy of autoimmune disease
AU3740000A (en) * 1999-03-25 2000-10-16 Center For Molecular Medicine And Immunology Sphingomyelin containing preparation for the enhancement of tumor therapy
KR101442047B1 (ko) 2005-09-22 2014-09-18 유키지루시 메그밀크 가부시키가이샤 스핑고미엘린 함유 의약, 음식품 또는 사료
US9056129B2 (en) * 2007-02-09 2015-06-16 Northeastern University Precision-guided nanoparticle systems for drug delivery
US20140205543A1 (en) 2013-01-24 2014-07-24 Memorial Sloan-Kettering Cancer Center Method for diagnosing or treating tumors using sphingomyelin containing liposomes
JP2017505301A (ja) * 2014-01-08 2017-02-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 転移性播種を予防又は低減するための方法及び医薬組成物
GB201414464D0 (en) * 2014-08-14 2014-10-01 Technion Res & Dev Foundation Compositions and methods for therapeutics prescreening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
EP0742789B1 (de) * 1994-02-02 2000-08-30 The Liposome Company, Inc. Pharmazeutisch wirksame verbindungen und liposome und verfahren zu deren herstellung
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
RU2156127C2 (ru) * 1995-12-28 2000-09-20 Еситоми Фармасьютикал Индустриз, Лтд. Препарат местного применения для иммуносупрессии и лечения аутоиммунных или аллергических заболеваний
CA2286177C (en) * 1997-04-07 2011-06-21 Daiichi Pharmaceutical Co., Ltd. Composition for gene transfer into cells
AU3740000A (en) * 1999-03-25 2000-10-16 Center For Molecular Medicine And Immunology Sphingomyelin containing preparation for the enhancement of tumor therapy

Also Published As

Publication number Publication date
CA2707691C (en) 2013-09-03
US6541462B1 (en) 2003-04-01
WO2000057916A1 (en) 2000-10-05
CA2368676A1 (en) 2000-10-05
EP1165137A1 (de) 2002-01-02
CA2368676C (en) 2010-09-07
JP2002540172A (ja) 2002-11-26
DE60029762D1 (de) 2006-09-14
AU3740000A (en) 2000-10-16
ES2269121T3 (es) 2007-04-01
EP1666045A1 (de) 2006-06-07
CA2707691A1 (en) 2000-10-05
DE60029762T2 (de) 2007-10-18
ATE512664T1 (de) 2011-07-15
EP1165137B1 (de) 2006-08-02
US7288534B2 (en) 2007-10-30
US20030228257A1 (en) 2003-12-11
EP1666045B1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
ATE312103T1 (de) Substituierte porphyrine und deren therapeutische verwendungen
DK0612248T3 (da) Præparat, der indeholder cisplatin og topotecan som antitumormiddel
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
DE50310516D1 (de) Fredericamycin-derivate
MY125564A (en) Combination therapy for treatment of psychoses
HK1060067A1 (en) Compositions for antitumour treatment containing ecteinascidin 743
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
ATE412771T1 (de) Verfahren zur modulation der tubulindeacetylase- aktivität
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
DK0944389T3 (da) Oprensede sammensætninger af 10-propargyl-10-deazaaminopterin og fremgangsmåder til anvendelse deraf i behandlingen af tumorer
ATE376824T1 (de) Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
ATE334686T1 (de) Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
SE0102147D0 (sv) New methods
SE9802937D0 (sv) Novel compounds
ATE406897T1 (de) Kombination von et-743 mit 5-fluorouracil pro- drugs zur behandlung von krebs
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
ATE334590T1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
TR199901782T2 (xx) Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
KR960700734A (ko) 사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers)
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties